T he replication of human immunodeficiency virus type 1 (HIV-1) is potently blocked in Old World monkeys at an early postentry step, prior to reverse transcription (1, 2). In 2004, TRIM5␣ was identified as the major host factor that mediates this block (3). Since this discovery, the TRIM5 proteins of multiple mammalian species have been characterized, and the range of restricted viruses has expanded to include a variety of retroviruses (lentiviruses, a betaretrovirus, a gammaretrovirus, and spumaviruses) (4-16). A TRIM5 variant, TRIMCyp, which arose as a result of retrotransposition events involving TRIM5 and cyclophilin A, exhibits distinct restriction activities and has been identified in New World owl monkeys and some Old World macaque species (17-22). The wide existence of restricting TRIM5 variants suggests that they are part of a novel, widespread mechanism of innate immunity.
T he replication of human immunodeficiency virus type 1 (HIV-1) is potently blocked in Old World monkeys at an early postentry step, prior to reverse transcription (1, 2) . In 2004, TRIM5␣ was identified as the major host factor that mediates this block (3) . Since this discovery, the TRIM5 proteins of multiple mammalian species have been characterized, and the range of restricted viruses has expanded to include a variety of retroviruses (lentiviruses, a betaretrovirus, a gammaretrovirus, and spumaviruses) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) (16) . A TRIM5 variant, TRIMCyp, which arose as a result of retrotransposition events involving TRIM5 and cyclophilin A, exhibits distinct restriction activities and has been identified in New World owl monkeys and some Old World macaque species (17) (18) (19) (20) (21) (22) . The wide existence of restricting TRIM5 variants suggests that they are part of a novel, widespread mechanism of innate immunity.
TRIM5 proteins block viral infection in a species-specific manner. Rhesus monkey TRIM5␣ (TRIM5␣ rh ) potently blocks infection by HIV-1, whereas human TRIM5␣ (TRIM5␣ hu ) only modestly restricts HIV-1 infection but potently blocks infection of N-tropic murine leukemia virus (N-MLV) (3, 5, 8, 9, 15) . The mechanism of TRIM5-mediated restriction is still not completely understood. Retroviral sensitivity is determined by viral capsid proteins; TRIM5␣ has been shown to bind directly to in vitroassembled HIV-1 capsid-nucleocapsid (CA-NC) complexes, which resemble authentic viral cores (23) (24) (25) . Interactions between TRIM5 proteins and viral capsids promote the uncoating of sensitive viruses, as the level of particulate capsids is decreased in the cytosol of cells expressing a restricting TRIM5␣ protein (25, 26) . Recent electron microscopic studies (27) demonstrated that purified TRIM5␣ proteins spontaneously form a large hexagonal lattice structure on the HIV-1 capsid, which is composed of smaller CA hexameric units. This observation has led to the hypothesis that a slight mismatch between the geometry of the TRIM5␣ rh hexagonal lattice and that of the capsid could lead to disassembly of the capsid (27) . Some investigators have reported that proteasome inhibitors relieve the TRIM5␣-mediated block of viral reverse transcription but not infection, implying a two-step restriction mechanism that requires the proteasome (28, 29) . Degradation of TRIM5 proteins was also observed in the presence of saturating levels of sensitive viruses, suggesting that the TRIM5␣-capsid complexes are targeted for degradation; however, changes in capsid protein stability or accumulation of ubiquitinated TRIM5␣ proteins were not observed upon HIV-1 infection (30) . Recognition of the retroviral capsid by TRIM5␣ has been shown to promote innate immune signaling by catalyzing the synthesis of unattached K63 ubiquitin chains (31) .
TRIM5␣ is a member of the tripartite motif (TRIM) protein family (32) . TRIM proteins all contain a RING domain, one or two B-box domains, and a coiled-coil domain. TRIM5␣, in addition, contains a B30.2/SPRY domain at the C terminus (32, 33) . The B30.2/SPRY domain determines viral specificity and restriction potency; sequence variations in this domain correlate with the ability of TRIM5 to recognize different viral capsids (34) (35) (36) (37) (38) (39) (40) . The coiledcoil domain of TRIM5 is essential for dimerization (41) . The RING and B-box 2 domains cooperatively promote the higherorder association of preformed TRIM5␣ dimers (42) (43) (44) . Multimerization increases TRIM5␣ avidity for viral capsids, which po-tentiates antiviral restriction. In both in vivo and in vitro assays, the TRIM5 RING domain has been shown to have E3 ubiquitin ligase activity (23, 24, 45) . The proposed involvement of the proteasome in blocking reverse transcription and the observed degradation of TRIM5 proteins upon infection of TRIM5-expressing cells with a sensitive virus both suggest that the E3 ubiquitin ligase activity of TRIM5 might play some role in restriction (28) (29) (30) . However, deletion or disruption of the RING domain of TRIM5␣ rh or TRIM5␣ hu only partially decreased restriction of HIV-1 and N-MLV infection, respectively, arguing against a necessary role of the E3 ubiquitin ligase activity in the TRIM5␣-mediated antiviral effect (35, 46, 47) . More recent data suggest that the contribution of the TRIM5␣ RING domain to restriction depends on both the host and the viruses (48) . The E3 ubiquitin ligase activity of TRIM5 agm correlated strongly with the restriction of macaque simian immunodeficiency virus (SIV mac ) infection, blockade of reverse transcription, and premature uncoating of the SIV mac capsid (49) . In light of these results, a reevaluation of the role of the RING domain and its associated E3 ubiquitin ligase activity in viral restriction is merited.
Although small, the TRIM5␣ RING domain is known to be multifunctional. Changes in this domain might simultaneously affect several properties of the protein, including the E3 ubiquitin ligase activity, higher-order self-association, protein turnover, and cellular localization (44, 46, 50) . To understand the contribution of each RING-determined property to antiviral activity, and whether different viruses are affected differently by these properties, we characterized comprehensively a panel of RING domain mutants of TRIM5␣ rh . We analyzed the correlations between these properties and the restriction of HIV-1, N-MLV, and equine infectious anemia virus (EIAV) infection. Our results indicated that the E3 ubiquitin ligase activity makes a modest contribution to the restriction of HIV-1 by TRIM5␣ rh . However, when the TRIM5␣ rh B30.2/SPRY domain was replaced by the TRIM5␣ hu B30.2/SPRY domain, which binds the HIV-1 capsid less efficiently, the ability to support higher-order association represented the dominant contribution of the RING domain to HIV-1 restriction. For TRIM5␣ rh restriction of N-MLV and EIAV, RING-mediated higher-order association contributed to restriction, whereas E3 ubiquitin ligase exerted little detectable impact on restriction. Thus, the antiviral potency of TRIM5␣ toward different viruses is dictated by distinct properties of the TRIM5 RING domain.
MATERIALS AND METHODS
Plasmid constructs and cell lines. All of the RING domain mutants were constructed by QuikChange mutagenesis, using as a template a pLPCX 
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vector encoding C-terminal hemagglutinin (HA)-tagged wild-type TRIM5␣ rh . In some cases, the sequences encoding the B30.2/SPRY domain from TRIM5␣ hu were substituted for the equivalent rhesus monkey TRIM5 sequence in the above vector, as previously described (51) . Stable Cf2Th cell lines were established using the pLPCX vector-based retroviral gene delivery system (Clontech) and selected in 5 g/ml puromycin, as previously described (52) .
Infection of cells with viruses expressing GFP. Recombinant HIV-1, N-MLV, B-tropic MLV (B-MLV), and EIAV viruses expressing green fluorescent protein (GFP) were made as previously described (3, 9, 12) . Cells were infected with various doses of GFP-expressing viruses, and the percentage of GFP-positive cells was counted 60 h after infection by fluorescence-activated cell sorting (FACS).
Assay for TRIM5␣ higher-order association. The association between dimers of TRIM5␣ rh RING domain mutants and the wild-type TRIM5␣ rh was assessed using a previously described higher-order selfassociation assay with some modifications (43, 44) . In 6-well plates, 293T cells were transiently transfected with the empty pLPCX vector or pLPCX vectors encoding the HA-tagged TRIM5␣ rh RING domain mutants or FLAG-tagged wild-type TRIM5␣ rh . Cell lysates were extracted 48 h after transfection and were cleared of insoluble materials/aggregates by centrifugation. Depending on the expression level of TRIM5␣ proteins, some lysates were further diluted with lysates from 293T cells transfected with the empty pLPCX vector. Lysates containing HA-tagged TRIM5␣ rh RING domain mutants and lysates containing FLAG-tagged wild-type TRIM5␣ rh were then mixed. Samples of the mixture were taken at this point for analysis of the input TRIM5␣ protein level. Magnetic protein G beads (7 l; Invitrogen), prebound with 1 l (ϳ5 to 6 g) of anti-FLAG antibody (Sigma), were added to the lysate mixture and incubated on a rocker overnight at 4°C. The beads were then washed four times with 1 ml buffer (300 mM NaCl, 50 mM Tris-HCl, 1% NP-40) at 4°C for 10 min before being boiled for 5 min in 2ϫ SDS sample buffer (125 mM TrisHCl, 2% SDS, 16% glycerol, 3% ␤-mercaptoethanol, 0.01% bromophenol blue) to release the immunoprecipitated proteins. The proteins were analyzed by Western blotting, using the HA and FLAG epitopes for detection, as described previously (43, 44) .
In vitro E3 ubiquitin ligase activity assay. The E3 ubiquitin ligase activity of TRIM5␣ variants was measured using a previously described in vitro self-ubiquitylation assay with minor modifications (49) . Cf2Th cells stably expressing the RING domain mutants were lysed in RIPA buffer (50 mM Tris-HCl [pH 7.4], 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, 0.1% SDS, and protease inhibitor cocktail) supplemented with 0.5 mM dithiothreitol (DTT). After preclearing by centrifugation, the cell lysates were mixed with magnetic protein G beads (7 l; Invitrogen) prebound with 5 g of anti-HA antibody (Sigma) and incubated overnight at 4°C on a rocker. The beads were then washed 4 times with RIPA buffer supplemented with 0.5 mM DTT and once with HEPES buffer (50 mM HEPES, 200 mM NaCl, and 0.5 mM DTT). For the self-ubiquitylation reaction, the beads were resuspended in HEPES buffer and mixed with 0.2 M E1 enzyme, 1 M E2 enzyme (UbcH5a), and 20 M ubiquitin in the presence and absence of an energy-regenerating system (5 mM Mg-ATP; BostonBiochem). The reaction mixture was incubated at 37°C for 2 h. TRIM5␣ proteins were then detected by Western blotting with an an- 
The expression level of each TRIM5␣ variant was determined as described in Materials and Methods. The level relative to that of the wild-type TRIM5␣ rh protein is reported as follows: ϩϩϩϩ, more than 300% of the wild-type TRIM5␣ rh level; ϩϩϩ, 150 to 300%; ϩϩ, 100 to 150%; ϩ, 40 to 55%. b The ubiquitin ligase activity of each TRIM5␣ variant was determined as described in Materials and Methods. The E3 ubiquitin ligase activity relative to that of the wild-type TRIM5␣ rh protein is reported as follows: ϩϩϩϩ, 100 to 101% of the wild-type TRIM5␣ rh E3 ligase activity; ϩϩϩ, 60 to 70%; ϩϩ, 40 to 50%; ϩ, 5 to 15%; Ϫ, not detected. c The higher-order association of each TRIM5␣ variant with the wild-type TRIM5␣ rh protein was determined as described in Materials and Methods. The association efficiency relative to the self-association of wild-type TRIM5␣ rh protein is reported as follows: ϩϩϩϩ, Ն100% of the higher-order self-association of the wild-type TRIM5␣ rh protein; ϩϩϩ, 80 to 95%; ϩϩ, 10 to 30%; ϩ, 0 to 10%; Ϫ, not detected. ti-HA antibody (Roche). For densitometric analysis, films were scanned digitally, and the relative intensities of protein bands were quantitated by using the ImageJ 1.42q software (NIH). The E3 ubiquitin ligase activity is expressed as the amount of the unmodified TRIM5␣ protein after the ubiquitylation reaction subtracted from the amount of input TRIM5␣ protein, divided by the amount of the input TRIM5␣ protein. For mutants that exhibited no E3 ubiquitin ligase activity, film quantitation occasionally yielded small negative values; in those cases, the E3 ubiquitin ligase activities were assigned a value of zero. Detergent solubility assay. To assess the solubility of TRIM5␣ rh variants in detergent buffers, 4 ϫ 10 5 stable Cf2Th cells expressing TRIM5␣ RING domain mutants were seeded into 6-well plates. Cells were lysed the following day with 1 ml of lysis buffer (1% NP-40 -phosphate-buffered saline-protease inhibitor cocktail). The detergent-soluble and -insoluble fractions represented the supernatant and the pellet obtained by centrifuging crude cell lysates at 13,200 rpm for 10 min. The pellet was dissolved in SDS sample buffer, and the amounts of proteins in both the supernatant and the pellet were examined by Western blotting with an anti-HA antibody (Roche). Detergent insolubility was defined as the ratio of insoluble protein to soluble protein, both normalized against the ␤-actin level in the respective fractions.
Subcellular localization using immunofluorescence confocal microscopy. The subcellular localization of TRIM5␣ mutants was detected with a rat anti-HA 3F10 antibody (1:100; Roche) followed by a goat antirat immunoglobulin G conjugated with Alexa-488 (1:200; Molecular Probes) and observed under a Zeiss LSM510 META confocal microscope, as previously described (43) .
Measurement of HIV-1 late reverse transcription products. One day prior to infection, 4 ϫ 10 5 stable TRIM5␣-expressing Cf2Th cells were seeded into 6-well plates in triplicate. HIV-1-GFP viruses were prepared as described above and were treated with 44 U/ml of Turbo DNase I (Ambion) at 37°C for 1 h. The viruses were then added to cells at a dose that would infect 50 to 80% of cells expressing the empty pLPCX vector. Sixteen hours after infection, cells were harvested and total DNA was extracted with the DNeasy kit (Qiagen). One hundred nanograms of total DNA was used as a template for quantitative real-time PCRs under previously described conditions (53) . Duplicate measurements were performed for each of the triplicate samples.
Statistics. Potential relationships between variables were examined by Spearman rank-order correlation analysis (Vassarstats.net). To account for multiple comparisons, only correlations with P values of Ͻ0.02 were considered significant.
RESULTS

Antiretroviral activities of TRIM5␣ rh RING domain mutants.
The solution structure of the human TRIM5␣ RING domain has been solved (doi:10.2210/pdb2ecv/pdb). Like other RING domains, the TRIM5␣ hu RING coordinates two zinc ions and adopts a ␤␤␣ fold (54) . Based on homology with some well-characterized RING domains, several residues in the TRIM5␣ rh RING domain (I17, L19, V58, R60, A41, and N42) were predicted to be at or near the putative E2 binding site (54) . To study the contribution of these residues to the E3 ubiquitin ligase activity of TRIM5␣ and retrovirus restriction, we changed these residues to alanines (A) (except A41, which was changed to glutamine [Q]), either individually or in combination.
Previously, we showed that the RING domain contributes to the higher-order self-association of TRIM5␣ (44) . A closely re- lated chimeric protein, TRIM5␣ rh -21R, which is a TRIM5␣ rh protein with a human TRIM21 RING domain, exhibits much less efficient higher-order self-association than wild-type TRIM5␣ rh (unpublished results). By comparing the RING domains of human TRIM21 and TRIM5␣ rh , several residues (E20, L21, M47, and L48) were identified as potential contributors to higher-order self-association. These residues were also changed to alanines, either individually or in combination, to investigate the contribution of RING domain-mediated higher-order self-association to restriction.
Cf2Th cell lines stably expressing these double or single TRIM5␣ rh mutants were established, and the steady-state level of TRIM5␣ expression was examined (Fig. 1A) . These cells were then challenged with recombinant HIV-1, N-MLV, EIAV, or B-MLV viruses expressing GFP (Fig. 1B) . Some mutants, particularly E20A/L21A and L21A, were expressed at much higher levels than others, but higher expression levels did not significantly correlate with restriction potency (Tables 1 and 2 ). For example, the mutant M47A/L48A, although expressed at a lower level, restricted HIV-1, N-MLV, and EIAV infection as efficiently as wild-type TRIM5␣ rh . Most of the RING domain mutants potently restricted HIV-1 infection, with a few mutants exhibiting very modest reductions in their anti-HIV-1 activity. All of the mutants potently restricted infection by EIAV. In contrast to the two lentiviruses, the gammaretrovirus N-MLV was able to overcome the block by many of the RING domain mutants. For example, mutant L21A blocked HIV-1 infection even more potently than wild-type TRIM5␣ rh , yet exerted little effect on N-MLV infection (Fig. 1B) ; this observation suggests that the TRIM5␣ rh RING domain may contribute to HIV-1 and N-MLV restriction by different mechanisms. Neither wild-type TRIM5␣ rh nor any of these mutants was able to block infection by B-MLV (Fig. 1B) .
E3 ubiquitin ligase activity of TRIM5␣ rh RING domain mutants. The E3 ubiquitin ligase activity of the TRIM5␣ rh RING domain mutants was examined in an in vitro assay, as previously described (49) . The wild-type TRIM5␣ rh efficiently formed polyubiquitin ladders upon addition of ATP ( Fig. 2A) . Two mutants, A41Q/N42A and M47A/L48A, self-ubiquitylated as efficiently as the wild-type TRIM5␣ rh protein. All other mutants exhibited some degree of defect in their E3 ubiquitin ligase activity. The L19A, I17A/L19A, V58A, R60A, and V58/R60A mutants exhibited no detectable E3 ubiquitin ligase activity, consistent with the prediction that the E2 binding site is disrupted by these changes (54) . The relationship between the E3 ubiquitin ligase activity of the TRIM5␣ rh mutants and their ability to restrict retroviral infection was investigated by a Spearman rank-order correlation analysis (Vassarstats.net). The viral infection results from four independent experiments were averaged and used in the analysis. The E3 ubiquitin ligase activity was quantified as the percentage of proteins ubiquitylated after the in vitro reaction. The relationships between the E3 ubiquitin ligase activity and the restriction activities are shown in Fig. 2B . A positive correlation was observed between the E3 ubiquitin ligase activity and the ability of TRIM5␣ rh to block HIV-1 infection, even though mutant TRIM5␣ rh proteins with poor E3 ubiquitin ligase activity (e.g., V58A) still restricted HIV-1 quite efficiently. No correlation with the E3 ubiquitin ligase activity was observed for the TRIM5␣ rhmediated restriction of either N-MLV or EIAV infection (Fig. 2B) .
Higher-order association of TRIM5␣ rh RING domain mutants. We previously showed that higher-order self-association of TRIM5␣ protein dimers promotes cooperative binding to the HIV-1 capsid (42, 43) . Electron microscopy studies have demonstrated that purified TRIM5␣ proteins spontaneously form a hexagonal lattice structure, which is promoted by interaction with the assembled HIV-1 capsid (27) . The hexagonal lattice structure likely forms as a result of TRIM5␣ higher-order selfassociation, allowing "pattern recognition" of viral capsids (27) . The TRIM5␣ rh mutants dimerized efficiently, compared with the wild-type TRIM5␣ rh protein; the L19A and A41Q/N42A mutants exhibited slight decreases in dimerization, which may be related to their lower levels of expression (data not shown). As the RING domain contributes to TRIM5␣ higher-order self-association, we examined whether the RING domain mutants associated with wild-type TRIM5␣ rh dimers to form higher-order structures, using a previously described coimmunoprecipitation assay with differently tagged proteins (see Materials and Methods) (43, 44) .
To achieve equivalent input levels of the TRIM5␣ rh variants, some of the cell lysates were diluted with the lysates from 293T cells transiently transfected with the empty pLPCX vector. Three of the mutants (M47A/L48A, A41Q/N42A, and R60A) associated with TRIM5␣ rh dimers as efficiently as the wild-type TRIM5␣ protein; all the other mutants demonstrated some degree of defect in higher-order association (Fig. 3A) . No significant correlation was observed between higher-order association and the restriction of HIV-1 infection for this panel of mutants (Fig. 3B) . In contrast, there was a very strong correlation between TRIM5␣ rh higherorder association and the restriction of N-MLV infection. A weaker correlation was also observed between higher-order association and the restriction of EIAV infection. Thus, the contribution of the TRIM5␣ rh RING domain to higher-order association is apparently more important for N-MLV and EIAV restriction than for HIV-1 restriction.
Higher-order association and capsid binding. The binding of the RING domain mutants to the HIV-1 capsid was examined by using a previously described assay in which TRIM5␣ cosediments with in vitro-assembled HIV-1 CA-NC complexes (25, 55) ( Fig. 4A and B) . We observed a strong correlation between capsid binding ability and higher-order association efficiency for these mutants, confirming that RING-dependent higher-order association can enhance capsid-binding avidity (Fig. 4C) . For this panel of RING domain mutants, we did not observe a correlation between HIV-1 restriction and the ability of the mutant TRIM5␣ rh proteins to associate with HIV-1 CA-NC complexes (Table 2) . We hypothesized that because these mutants all have a wild-type B30.2/SPRY domain from TRIM5␣ rh , which efficiently binds the HIV-1 capsid, the contribution of RING-mediated higher-order self-association to HIV-1 restriction is less critical. Moreover, because the RING domain mutants defective for higher-order association tend to be expressed at higher levels in cells (Fig. 1A and Table 1 ), higher concentrations of these mutants may compensate for lower capsid avidity.
We asked whether the requirements of retroviral restriction for specific TRIM5␣ RING functions depended on capsid binding affinity, which is primarily dictated by the B30.2/SPRY domain (34) (35) (36) (37) (38) (39) (40) . To that end, the B30.2/SPRY domain of TRIM5␣ hu was substituted for the B30.2/SPRY domain of wild-type TRIM5␣ rh and three RING domain mutants of TRIM5␣ rh . TRIM5␣ hu binds the HIV-1 capsid and restricts HIV-1 infection less efficiently than TRIM5␣ rh , but it restricts N-MLV infection more efficiently than TRIM5␣ rh (3, 9, 25, 55) ; the TRIM5␣ B30.2/SPRY domain determines these phenotypes (35, 36, 39, 40, 51, 55, 56) . Figure 5 shows the effects of the TRIM5␣ variants on infection by HIV-1 and N-MLV. The TRIM5␣ variants were expressed at comparable levels, except for the highly expressed L21A and the L21A-huSPRY mutants (Fig. 5A) ; the L21A-huSPRY mutant contains the L21A change in a TRIM5␣ rh chimera with a TRIM5␣ hu B30.2/SPRY domain. As expected, the huSPRY chimeras restricted HIV-1 infection less efficiently than the TRIM5␣ rh variants. Of interest, HIV-1 inhibition by the huSPRY variants correlated with higherorder association (r s ϭ 0.8), and not with E3 ubiquitin ligase activity (r s ϭ 0.4). Thus, when the interaction of the B30.2/SPRY domain with the retroviral capsid is relatively weak, the importance of the higher-order association function of the RING domain to restriction increases. Lysates from 293T cells transiently expressing the HA-tagged TRIM5␣ rh variants were incubated with assembled HIV-1 CA-NC complexes, which were pelleted through a sucrose cushion and analyzed as previously described (25) . To achieve equivalent input levels of TRIM5␣ rh protein, some cell lysates were diluted with cell lysates from 293T cells transfected with the empty vector pLPCX. For comparison purposes, the cell lysates containing wild-type TRIM5␣ rh were diluted as indicated in panel B. ␣-HA, anti-HA antibody. (C) The relationship between higher-order association and HIV-1 CA-NC binding was assessed by Spearman rank-order correlation analysis.
The huSPRY chimeras all restricted N-MLV infection potently (Fig. 5B) . In this case, the restriction potency of the chimeras correlated with higher-order association (r s ϭ 1), and not with E3 ubiquitin ligase activity (r s ϭ 0.2). Thus, promoting higher-order association appears to be the predominant contribution of the TRIM5␣ RING domain to N-MLV restriction, regardless of the B30.2/SPRY contribution to capsid interaction.
Formation of HIV-1 late reverse transcripts. To examine how the RING domain changes affect HIV-1 restriction by TRIM5␣ rh , we studied HIV-1 late reverse transcript (RT) formation in cell lines expressing TRIM5␣ rh RING domain mutants. HIV-1 late RTs were measured 16 h after infection with HIV-1-GFP viruses at a viral dose that would infect approximately 50 to 80% of the cells transduced with the empty pLPCX vector. Most of the TRIM5␣ rh mutants potently blocked RT formation, whereas a few were less efficient in this regard (Fig. 6A) . A good correlation was observed between the level of HIV-1 infection and the late RT level in cells (Fig. 6B) . Of note, we did not identify any RING domain changes that uncoupled inhibition of HIV-1 reverse transcription and restriction of infection. The correlation between HIV-1 late RT formation and the E3 ubiquitin ligase activity for these TRIM5␣ rh mutants fell short of statistical significance (Fig. 6B) . Indeed, despite exhibiting no detectable E3 ubiquitin ligase activity in the in vitro assay, some mutants (e.g., V58A, R60A) potently blocked HIV-1 late RT formation. Thus, restriction of HIV-1 infection by this panel of TRIM5␣ rh RING mutants is closely linked to disruption of reverse transcription.
The effect of protein turnover on antiviral activities and other protein properties. As changes in the RING domain have been reported to affect the turnover of TRIM5 proteins, we measured the half-lives of the RING domain mutants, as previously described (50, 52) . Some changes in the RING domain significantly reduced the turnover of the TRIM5␣ rh protein; the stable, steady-state expression level of these mutants correlated with their respective half-life ( Fig. 7 and Table 3 ). An inverse correlation was observed between the half-life of the RING mutants and higherorder association, as well as two other properties, HIV-1 CA-NC binding and N-MLV restriction, which are linked to higher-order association (Table 2 and 3) .
Formation of detergent-insoluble aggregates in cells. By using a detergent solubility assay, we examined if the TRIM5␣ rh RING domain mutants could be extracted with buffer containing 1% NP-40. The wild-type TRIM5␣ rh was largely soluble in this buffer, and the majority of the protein partitioned into the supernatant (Fig. 8) . Some mutants were resistant to detergent extraction, and a significant amount of the protein could be detected in the detergent-insoluble pellet fraction (Fig. 8) . The tendency to form detergent-insoluble complexes was independent of the expression level or half-life, as some mutants with a high expression level (e.g., L21A) were still quite soluble (Fig. 8) . Immunofluorescence staining showed that mutants with high detergent insolubility formed juxtanuclear inclusion bodies that were reminiscent of aggresomes or cellular inclusion bodies (Fig. 9) (57) . The detergent insolubility index was defined as the ratio of the insoluble TRIM5␣ rh proteins in the pellet to the soluble proteins in the supernatant, both normalized to the actin level in the corresponding fractions. The detergent insolubility index inversely correlated with restriction of HIV-1 and EIAV and exhibited a trend toward an inverse correlation with N-MLV restriction (Table 2) . Detergent insolubility also negatively correlated with the E3 ubiquitin ligase activities of these mutants. Detergent insolubility may reflect suboptimal folding of the RING domain, with some associated aggregation in expressing cells as well as functional impairment. 
DISCUSSION
In this study, we assayed multiple properties of a panel of TRIM5␣ rh RING domain mutants, including two properties, E3 ubiquitin ligase activity and higher-order association, to which the TRIM5␣ RING domain contributes. Our results revealed the relationships among these properties and TRIM5␣ rh restriction of infection of two lentiviruses, HIV-1 and EIAV, and a gammaretrovirus, N-MLV.
E3 ubiquitin ligase activity correlated with the potency of restriction of HIV-1 infection by TRIM5␣ rh RING mutants, consistent with previously reported results (58) . However, the E3 ubiquitin ligase function of the RING domain affected HIV-1 restriction potency over a relatively narrow range. All the mutants examined were able to restrict HIV-1 infection with at least moderate potency. Moreover, some of the E3 ubiquitin ligase-defective TRIM5␣ rh mutants (e.g., V58A, R60A) potently blocked HIV-1 reverse transcription. Thus, RING-mediated E3 ubiquitin ligase activity, at least as measured in our in vitro autoubiquitylation assay, does not appear to be absolutely essential for the early blockade of HIV-1 infection. Lienlaf et al. also found that the V58A and R60A TRIM5␣ rh mutants were defective for autoubiquitylation yet reduced HIV-1 reverse transcription by more than 10-fold (58) . However, they reported only weak restriction of HIV-1 infection by these mutants, a result that is unexpected in light of the reverse transcription decrease and in contrast to the significant HIV-1 restriction activity observed in our study. Despite these differences, both studies support a role for TRIM5␣ rh ubiquitin ligase activity in HIV-1 infection.
Some caveats apply in extrapolating our results to reach conclusions about the role of RING-mediated E3 ubiquitin ligase activity in TRIM5␣ rh function in vivo. The in vitro autoubiquitylation assay is a sensitive and commonly used method to assess E3 ubiquitin ligase activity when the substrate is unknown (59) , and the E2 enzyme used in this study (UbcH5a) was selected by screening a battery of different E2 enzymes (49) . Nonetheless, given that an E3 ubiquitin ligase could potentially utilize numerous E2s in vivo, changes in the TRIM5␣ RING domain might differentially affect its interactions with a physiological E2 partner(s) (54, 60) . A second caveat is that the phenotype of E3 ubiquitin ligase-defective TRIM5␣ mutants may depend upon the level of TRIM5␣ expression. Although our results are corroborated by the observation that RING-deleted TRIM5␣ rh mutants retain some HIV-1- restricting activity (35, 46, 47) , infection inhibition assays are typically performed with cells expressing higher-than-physiologic levels of mutant TRIM5␣ proteins. In natural target cells for HIV-1 infection, where TRIM5␣ expression is lower, RING-mediated E3 ubiquitin ligase activity may assume greater importance.
The precise mechanism by which E3 ubiquitin ligase activity contributes to the potency of HIV-1 restriction requires further investigation. Notably, the RING function important for HIV-1 restriction potency differed in the context of TRIM5␣ rh , which binds the HIV-1 capsid tightly, and the chimeric TRIM5␣ rhhuSPRY protein, in which the replacement of the TRIM5␣ rh B30.2/SPRY domain with that of human TRIM5␣ results in a decreased affinity for the HIV-1 capsid. In the restriction of HIV-1 infection by TRIM5␣ rh -huSPRY, the contribution of the RING domain to higher-order association superseded the contribution of the RING domain to E3 ubiquitin ligase activity. Apparently, in the context of the TRIM5␣ rh -huSPRY chimera, where the affinity of the B30.2/SPRY domain for the HIV-1 capsid is low, the contribution of higher-order association to capsid binding avidity becomes more important for successful HIV-1 restriction. This result is reminiscent of the effect of B30.2/SPRY-mediated capsid binding affinity on the HIV-1 restriction phenotypes resulting from changes in the TRIM5␣ B-box, which cooperates with the RING domain to achieve higher-order self-association (43, 51) . Capsid binding affinity specified by the B30.2/SPRY domain also influenced the consequences of RING domain changes on the restriction of SIV mac infection by TRIM5␣ of African green monkeys (49) .
Several of the TRIM5␣ rh RING mutants exhibited deficiencies in higher-order association, consistent with a previous study implicating the RING domain as a contributor to the higher-order association of TRIM dimers (44) . Significant correlations were found between TRIM5␣ rh higher-order association and the restriction of N-MLV infection. These results clearly contrasted with those obtained for restriction of HIV-1 infection by the TRIM5 rh RING domain variants. For example, the L21A TRIM5␣ rh mutant, which exhibited poor higher-order association, was able to restrict HIV-1 as potently as the wild-type TRIM5␣ rh protein but completely lost its ability to restrict N-MLV. Even when the N-MLV restriction potency was augmented by a B30.2/SPRY domain replacement from TRIM5␣ hu , RINGdetermined higher-order association exhibited the strongest correlation with N-MLV restriction. The different phenotypes of the TRIM5␣ RING mutants with respect to HIV-1 and N-MLV restriction may reflect differences in the formation or consequences of the hexagonal TRIM5␣ lattice on the conical and spherical capsids, respectively, of HIV-1 and N-MLV. The relative importance of TRIM5␣ higher-order association and the formation of a TRIM5␣ lattice to N-MLV restriction are consistent with the observation that changes that allow N-MLV to escape TRIM5␣ rh restriction map over a large surface of the viral capsid (61).
Higher-order association of the TRIM5␣ rh RING domain mutants apparently exerted a larger influence than E3 ubiquitin ligase activity on the restriction of EIAV infection. Nonetheless, all of the RING domain mutants exhibited quite potent inhibition of EIAV infection. Thus, like HIV-1 restriction by TRIM5␣ rh , inhibition of EIAV infection by TRIM5␣ rh in this context is not absolutely dependent on either of the RING functions measured in our assays. This is consistent with the retention of lentivirus restriction activity for TRIM5␣ variants completely lacking the RING domain (3, 46, 47) . Perhaps, as discussed above, features of the lentivirus conical capsid diminish the requirement for RING domain function during the restriction process. The previously mentioned caveats about generalizing our results to in vivo lentivirus infections apply here to EIAV as well.
Higher-order association of the TRIM5␣ rh RING domain variants correlated significantly with TRIM5␣ binding to HIV-1 CA-NC complexes, as expected from the contribution of TRIM5␣ rh higher-order structures to capsid binding (27, 43, 44) . TRIM5␣ rh mutants that associated to form higher-order structures also exhibited shorter half-lives and lower steady-state levels of expression in stably expressing cell lines. Thus, although higher-order self-association is conducive to the TRIM5␣-capsid interaction, it may predispose to the formation of aggregates that need to be avoided or processed to maintain optimal cell growth (57) . Neither the E3 ubiquitin ligase activity nor detergent insolubility of the TRIM5␣ rh variants significantly correlated with the half-life or steady-state expression level of the proteins. The mechanism of TRIM5␣ turnover in these stably expressing cells is unclear. A slower-migrating band reminiscent of ubiquitylated TRIM5␣ was consistently observed in detergent-insoluble pellets (Fig. 8) , even for mutants with no or very weak E3 ubiquitin ligase activity. Other E3 ubiquitin ligases in the cells likely ubiquitylate TRIM5␣ and could potentially play a role in its turnover.
In summary, the correlations identified in this study delineate how the identity of the targeted retrovirus influences the contributions of TRIM5␣ RING domain functions to antiviral restriction. Different retroviruses apparently require distinct properties of TRIM5 proteins for efficient restriction. Detailed structural information on the interactions between TRIM5␣ proteins and ret- cells stably expressing the HA-tagged TRIM5␣ rh variants were stained with an anti-HA antibody, followed by an anti-rat secondary antibody conjugated to Alexa-488. The TRIM5␣ rh proteins are shown in green, and the nuclei were stained blue with 4=,6-diamidino-2-phenylindole. roviral capsids should shed light on how TRIM5␣ recognizes and disassembles the capsids of different viruses.
